Amy Shen is the Provost and a Professor at OIST in Japan, where she has led the Micro/Bio/Nanofluidics Unit since 2014. Before joining OIST, she was a faculty member in Mechanical Engineering at the University of Washington, USA. Her research focuses on microfluidics, rheology, and lab-on-a-chip technologies at the bio/nano interface, with broad applications in biotechnology. Amy is a Fellow of the American Physical Society, the Royal Society of Chemistry, and the Society of Rheology. She has received numerous accolades, including the NSF CAREER Award, the Ralph E. Powe Junior Faculty Enhancement Award, and was a Fulbright Scholar in 2013. She serves as an Associate Editor for Soft Matter and is on the editorial advisory boards of ACS Sensors, Journal of Rheology, and Physics of Fluids. Notably, she delivered the 2019 Bergveld Lecture at the University of Twente in the Netherlands and the 2025 FlOW lecture at KTH Royal Institute of Technology in Sweden.

Prof. Chenzhong LI is the X.Q. Deng Presidential Chair Professor of the Chinese University of Hong Kong (Shenzhen) (CUHKSZ), the co-editor-in-chiefs of the international flagship journal Biosensor and Bioelectronics.

Before joining CUHK Shenzhen in 2023, Li helds positions such as the research officer at the National Research Council Canada (NRC), the World Ahead professor at Florida International University, the professor of Biomedical Engineering at Tulane University, and the Program Director in the Chemical, Bioengineering, Environmental and Transport Systems (CBET) Division of National Science Foundation to oversee AI biosensors and biomedical devices research and manage grants for hundreds of research projects nationwide.

Li is an expert in bioinstrumentation, specifically in the development of biomedical devices for both diagnostic and therapeutic, which could also have cross-applications for environmental, food safety monitoring, agriculture, and homeland security.

Li is the Member of the Canadian Academy of Engineering, Member of the National Academy of Inventors, AIMBE fellow of the American Academy of Medical Biological Sciences. By 2025, he has published nearly 210 research papers, and is the main inventor of 21 international patents. He was the founder and technical director of three start-up companies in China, the United States, and Canada.

Professor Chwee Teck Lim is the NUSS Chair Professor and Director of the Institute for Health Innovation and Technology at the National University of Singapore. He is globally recognised for his research on pioneering novel medical technologies to transform healthcare. His prolific academic journey includes over 500 published journal articles and over 550 plenary/keynote/invited talks. A serial entrepreneur, he co-founded six startups with one achieving successful IPO in 2018. Prof Lim is globally recognized for his distinguished achievements by the over 100 research awards and honors including the Nature Lifetime Achievement Award for Mentoring in Science, Highly Cited Researcher, Asia’s Most Influential Scientist Award, Asian Scientists 100, Wall Street Journal Asian Innovation Award and the President's Technology Award. He is also an Elected Fellow of nine academies including the Royal Society (UK), National Academy of Inventors (US), IUPESM, IAMBE, AIMBE, ASEAN Academy of Engineering and Technology, Singapore National Academy of Science, Academy of Engineering, Singapore and Institution of Engineers, Singapore.

Professor Yang Fang is a Chief Professor and Doctoral Supervisor at Southeast University, honored with the National high-level talents. Her research is centered on cutting-edge technologies in ultrasound medicine, including intelligent micro/nano-bubble delivery systems, multimodal ultrasound imaging, and image-guided precision drug delivery and sensors. She has authored over 100 SCI-indexed publications in high-impact journals such as Advanced Materials, Science Advances, ACS Nano, and Advanced Science. She has comprised 11 national invention patents and 1 international PCT patent. Furthermore, she has led the development of one ISO international standard. Professor Yang's contributions have been recognized with several esteemed awards, including the Natural Science First-Class Award from the Ministry of Education, a Special Gold Medal at the 46th International Exhibition of Inventions Geneva, and the First Prize of the Jiangsu Provincial Science and Technology Award. She also holds leadership roles in the academic community, serving as the associate directors of Imaging Materials and Technology Branch at the Chinese Society for Biomaterials, and Vascular Branch at Chinese Society for Anatomical Sciences, etc.

Professor Hsueh-Chia Chang is the Bayer Professor of Chemical and Biomolecular Engineering at the University of Notre Dame. He has been at Notre Dame since 1987 and has served as the department chair and the director of the Center for Microfluidics and Nanofluidics. His research is in the area of micro/nanofluidics and diagnostics, particularly integrated devices for the isolation and characterization of exosomes and other nanocarriers. His research has resulted in 19 patented technologies, eight of them have been licensed by four startups: Cubed Laboratories, AgenDx, ImpeDx and Aopia Biosciences. Products developed from these IPs include CRDTM Botrytis Detection kit by CubedLabs and NanoExTM exosome purification technology by Aopia Bio. Professor Chang served as the Chief Scientific Advisor of FCubed LLC (predecessor of CubedLabs) for 4 years. He co-founded Aopia Bio in 2019 and currently serves as its interim CTO and Board member. Professor Chang has published more than 300 papers and has a Google h-index of 79. He is the co-author of a seminal book in microfluidics: "Electrokinetically Driven Microfluidics and Nanofluidics" by Cambridge University Press in 2009. Professor Chang founded a new journal, Biomicrofluidics of the American Institute of Physics, in 2006 and served for 12 years as its Chief Editor. More than 35 PhD and post-doc students from his laboratory have embarked on academic careers as tenure-track professors in all engineering and science disciplines over 5 continents (15 in the US), including Duke, Imperial, Johns Hopkins etc. They include a chancellor, a Provost, three Department Chairs, four endowed chairs and five NSF Career Awardees. Industrial alumni from his group hold manager/director positions at Merck, Gilead, Alcon, Genentech and other major biotech and world-leading microfluidic companies. Professor Chang is a fellow of APS, NAI and AIMBE. His microfluidics work has been recognized by the Frenkiel Award from APS, the Lifetime Achievement Award from AES and the 1st Source Bank Commercialization Award. He has also won the Notre Dame Provost Research Achievement Award and was recognized at half time during the 2024 game against Stanford.

Chen Jie, Ph.D., is a Fellow of the Canadian Academy of Engineering, a Fellow of the Institute of Electrical and Electronics Engineers (IEEE Fellow), a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the Asia-Pacific Artificial Intelligence Association. He currently serves as the Founding Dean of the School of Biomedical Engineering at Fudan University. His research areas include microfluidic in vitro diagnostic chips, organ-neural chips, biomedical integrated circuits and wearable devices, and AI-based mental health diagnosis and therapy. He has published 3 books and 265 papers in top international journals (PNAS, ACS Nano, Physical Review Letters, Small, Nature Microsystems & Nanoengineering, Nature npj Mental Health) and leading IEEE journals (Proceedings of the IEEE, IEEE Journal on Solid-State Circuits, IEEE Transactions on Circuits and Systems, IEEE Transactions on Biomedical Engineering, and IEEE Transactions on Biomedical Circuits and Systems) as well as in major international conferences. His research has been cited over 9,900 times, with an h-index of 48. He helped found two Bell Labs spin-off companies. One of them, Flarion Technologies Inc., focused on developing 4G wireless networks and was later acquired by QUALCOMM (San Diego, USA). The other company, iBiquity Digital, specialized in HD Radios, which are now widely used in BMW, General Motors, Ford, Toyota, and Honda vehicles and are available in major retail chains such as Walmart and Best Buy. In 2015, iBiquity Digital was acquired by DTS (California, USA).

Lorena Diéguez joined INL in 2014 as a Staff Researcher and is, since 2018, the leader of the Medical Devices research group. Her research is mainly devoted to Translational Medical Research in close collaboration with hospitals and focuses on the development of tools and solutions based on microfluidics, biosensors and nanotechnology towards early diagnosis and better understanding of diseases. She is also very interested in translating her technology from the lab to the clinic and is co-founder and CEO of the spin-off company RUBYnanomed in the field of liquid biopsy. Currently, she is also the Chair of the Working Group in Medical Devices at the ETPN (European Technology Platform in Nanomedicine). She obtained her Bachelors in Physics with a Major in Optoelectronics at the University of Santiago de Compostela in 2005, then completed her Masters in Nanotechnology at the University of Barcelona (UB) in 2007 and her PhD in Biosensors at the UB, the Institute for Bioengineering of Catalonia and the ETH Zürich. Her postdoc at the University of South Australia (2010-2013) was devoted to the study of rare cells from biological samples using microfluidics.

Martyn Boutelle is Professor of Biomedical Sensors Engineering in the Department of Bioengineering, Imperial College London, and Associate Provost for Estates Planning for Imperial College. His research group is multidisciplinary comprising bioengineers, scientists, and clinicians. He develops novel analytical science methods using microfluidics, electrochemical sensors / biosensors, and wireless electronics to make portable (sometimes wearable) monitoring devices for use as point of care devices – typically giving continuous real -time displays. He then uses these in a program of clinical science research focusing on the neonatal monitoring, acute traumatic brain injury, pesticide exposure monitoring. Martyn is past president of the International Society for Monitoring Molecules in Neuroscience, and a founder of the COSBID organization for studying acute human brain injury. He published > 200 papers, chapters and patents. He obtained a BSc and PhD in Chemistry from Imperial College and worked as an EP Abraham Research Fellow in the University of Oxford.

Dr. Luo is mainly engaged in the studying and developing on new methods and techniques of mass spectrometry for metabolisms. Dr. Luo has published more than 100 SCI articles and authorized more than 20 Chinese patents and PCT patents. She has charged four NSFC foundations, key R&D projects of the MOST, more 20 foundations and innovation platforms of the NDRC, the CAS, Guangdong Province and Shenzhen City.

Professor Pan Tingrui is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and the Royal Society of Chemistry (RSC). He is currently a Yangtze River Chair Professor of the University of Science and Technology of China and directs the Institute for Innovative Medical Devices (iMED). Before joining USTC, Professor Pan was a tenured Full Professor at UC Davis, where he initiated Global Research Experience in Advanced Technologies (GREAT) Program and directed Center for Nano and Micro-Manufacturing (CNM²). He is currently an Associate Editor of Annals of Biomedical Engineering (TBME) and Journal of Medical Devices (JMD) and serves on the editorial board of Bioengineering and Journal of Chinese Medicine. His research interests span a wide range of bioengineering frontiers, including iontronic sensing, tactile intelligence, medical wearables, microfluidic interfaces and laboratory intelligence. His group has authored over 100 referenced publications on high impact journals and has been granted more than 20 international patents. Notably, Professor Pan is well known for his invention of the world-first flexible iontronic sensor (FITS), as the latest generation of tactile sensing technology, which has been successfully translated from a laboratory prototype to a series of enabling industrial and medical products. For his contribution to both academic innovation and technology translation, Professor Pan has received numerous international awards and domestic recognitions, including the National Science Foundation (NSF) Early Career Development (CAREER) Award and Emerging Frontiers in Research and Innovation (EFRI) Award, Xerox Award, CES Innovation Award, UC Davis Outstanding Service Award, Outstanding Engineering Faculty Award, and the First Prize of China Innovation and Entrepreneurship Competition.

Valerie Taly is CNRS research director class 1 (DR1) and Group leader of Translational Research And Microfluidics group (TRAM) within the MEPPOT laboratory (Personalized medicine, pharmacogenomics and therapeutic optimization) located in the Cordeliers Research Center (Université Paris Cité/INSERM). Her research group performs interdisciplinary research aiming at developing microfluidic tools for cancer research in close collaboration with clinicians and researchers in oncology. In particular, this team has been pioneered in the development of droplet based digital PCR to detect tumor specific genetic and epigenetic alterations as well as on the applications of the developed technologies to clinically relevant questions including liquid biopsy analysis. She was co-director of the MEPPOT laboratory from 2019-2021. She is co-author of >135 scientific articles and co-inventor of 17 patents. She is regularly invited to set on various committees, boards and jurys. With Florine Maes and Jean-Christophe Baret, Valerie Taly is cofounder of Emulseo (2018, https://www.emulseo.com/), based in Bordeaux (South-West of France), a company developing high performance surfactants for microfluidic technologies and formulation dedicated to droplet microfluidic experiments. She is also co-founder, alongside Guillaume Gines, Benjamin Nayagom, Pierre Laurent-Puig & Yannick Rondelez, of METHYS Dx start-up company (2021, https://www.methysdx.com/) that develop innovative technologies for cancer patient follow-up. She is president and CSO of METHYS Dx. With the METHYS Dx team, her ambition is to actively contribute to the improvement of survival and quality of life of patients with cancer.

Dr. Xueji Zhang is Vice Chairman of the University Council, Shenzhen University, University distinguished Professor(highest rank） in the School of Biomedical Engineering at Shenzhen University, P.R. China, President of Shenzhen Institute of Healthcare Security. He is also professor at Univ. of Sci. & Technol Beijing, and Executive President of National Institute of Precision Medicine & Health, Beijing. He received his BSc. and Ph.D. from Wuhan University in 1989 and 1994, respectively. His postdoctoral work was completed at National Institute of Chemistry, Slovenia, Swiss Federal Institute of Technology, Zurich and New Mexico State University, Last Cruces, USA from 1995-1999. He was a research scientist, Sr. Scientist, Chief Scientist, Vice President and Sr. Vice President at World Precision Instruments, Inc. USA until 2010, when he joined USTB as National Chair Professor. His research interests span the disciplines of chemistry, biology, materials and medicine with an emphasis on studies of biosensing, biomedicine and biomaterials. His lab focuses on the development of intelligent sensors, wearable sensors, novel biosensors, tools and devices to study free radicals, cancer biomarkers, profiling changes in animal or human associated with diseases and exploiting this information for development of diagnostic and therapeutic approaches. In addition, his group investigates drug delivery, new energy and natural medicines. He serves as the chief editor of RCS Sensors & Diagnostics, Am J of Biomed Sci and has been editorial member of 25 international journals. He has received numerous national and international awards and honors including Member European Academy of Sciences, Member of Russian Academy of Engineering, Fellow of American Institute for Medical & Bioengineering, Fellow of Royal Chemical Society, Gottfried Wilhelm Leibniz Medal, Huawei Outstanding Contribution Medal, National Innovation Pioneer Award, China, Outstanding contribution Award of Chemical Sensors, China, Scientist of Year in China, Outstanding Engineer in China, and Simon Fellow of ICSC-World Lab. He is elected as top scientist in the world by Stanford University from 2019-2015. He is named as top 0.05% scientist by Scholar GPS, ranked No.5 in Biomedical Engineering, No. 7 in Biosensors , No. 753 in All fields in the world respectively in 2025. He has authored over 800 papers with 50,000 citations and H index of 115, and 8 books and over 200 patents and developed numerous sensors and instruments for commercialization.

Dr Yong Zhang is currently Chair Professor and Head of the Department of Biomedical Engineering at City University of Hong Kong (CityUHK). Prior to joining CityUHK, he was Provost Chair Professor of Biomedical Engineering at the National University of Singapore with over 20 years of experience. Professor Zhang's research interests include functional nanomaterials, microfabricated devices, and wearable/implantable technologies for medical applications. He has published more than 350 research papers in journals such as Nature Medicine, Nature Biomedical Engineering, and PNAS, delivered more than 70 plenary/keynote/invited talks at international conferences, and received many awards such as the Humboldt Research Award (Germany), the IES Prestigious Engineering Achievement Award (Singapore), and the Global STEM Professorship (Hong Kong). He is a Highly Cited Researcher (Clarivate Analytics), an elected Fellow of the Singapore Academy of Engineering (SAEng), the European Academy of Sciences and Arts (EASA), the American Institute for Medical and Biological Engineering (AIMBE), the Institute of Electrical and Electronics Engineers (IEEE), and the Royal Society of Chemistry (RSC).

Yoon-Kyoung Cho is currently a full professor in Biomedical Engineering and the dean of College of Information and Biotechnology at UNIST, Republic of Korea. She is a member of the National Academy of Engineering of Korea (NAEK), an associate editor of the journal ‘Lab on a chip’, a fellow of the Royal Society of Chemistry, and vice president of the Chemical and Biological Microsystems Society (CBMS). She earned her Ph.D. in Materials Science and Engineering from the University of Illinois at Urbana-Champaign in 1999, following her M.S. and B.S. in Chemical Engineering from POSTECH in 1994 and 1992, respectively. Prior to joining UNIST in 2008, she served as a senior researcher (1999–2008) at Samsung Advanced Institute of Technology (SAIT). Her current research focuses on lab-on-a-chip systems for detecting rare biomarkers, quantitative analysis of cell migration, and systems analysis of intercellular communication. Discover more at http://fruits.unist.ac.kr.
https://scholar.google.com/citations?user=Jc1mz_EAAAAJ&hl=en